AMY DUGGER: Open Payments
NPI 1508174236 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 8 payments from 6 companies in 2025. Trend: 2023 $41 · 2024 $34 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $136 |
| Kerecis Limited | 1 | $120 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Boston Scientific Corporation | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Fresenius USA Marketing, Inc. | 1 | $14 |
Products named: LOKELMA, Kerecis SurgiClose, BEXSERO, ENROUTE Transcarotid Neuroprotection System, Kerendia, VELPHORO.
Industry payments across FL — which companies pay providers there.
